SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences - Quaterly Results

10 Aug 2022 Evaluate
Net sales declined -6.71%  to  Rs. 19809.00 million from Rs. 21234.00 millions.Net profit declined -17.10% to Rs. 3315.00 millions from Rs. 3999.00 millions.Operating Profit reported a sharp decline to 5960.00 millions from 6473.00 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 19809.00 21234.00 -6.71 19809.00 21234.00 -6.71 79819.00 77800.00 2.60
Other Income 517.00 297.00 74.07 517.00 297.00 74.07 1787.00 893.00 100.11
PBIDT 5960.00 6473.00 -7.93 5960.00 6473.00 -7.93 20968.00 23980.00 -12.56
Interest 406.00 442.00 -8.14 406.00 442.00 -8.14 1349.00 709.00 90.27
PBDT 5554.00 6031.00 -7.91 5554.00 6031.00 -7.91 16426.00 21396.00 -23.23
Depreciation 1231.00 1167.00 5.48 1231.00 1167.00 5.48 4787.00 4511.00 6.12
PBT 4323.00 4864.00 -11.12 4323.00 4864.00 -11.12 11639.00 16885.00 -31.07
TAX 1008.00 865.00 16.53 1008.00 865.00 16.53 3060.00 2123.00 44.14
Deferred Tax -6.00 15.00 -140.00 -6.00 15.00 -140.00 458.00 -910.00 -150.33
PAT 3315.00 3999.00 -17.10 3315.00 3999.00 -17.10 8579.00 14762.00 -41.88
Equity 1024.00 1024.00 0.00 1024.00 1024.00 0.00 1024.00 1024.00 0.00
PBIDTM(%) 30.09 30.48 -1.30 30.09 30.48 -1.30 26.27 30.82 -14.77

Zydus Lifesciences Share Price

928.85 -7.50 (-0.80%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×